H. Manley

Learn More
OBJECTIVE To determine if repetitive sphenopalatine ganglion (SPG) blocks with 0.5% bupivacaine delivered through the Tx360(®) are superior in reducing pain associated with chronic migraine (CM) compared with saline. BACKGROUND The SPG is a small concentrated structure of neuronal tissue that resides within the pterygopalatine fossa (PPF) in close(More)
  • 1